Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

NCT06689956 · clinicaltrials.gov ↗

RECRUITING

Status

212

Enrollment

OTHER

Sponsor class

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Stage IA1 Endometrial Cancer FIGO 2023
Stage IA2 Endometrial Cancer FIGO 2023

Interventions

OTHER: Non-Interventional Study

Sponsor

Mayo Clinic